Table 2.
Studies on L-plastin in leukocytes.
Leukocyte types | Key words of the study | References |
---|---|---|
Innate immunity | ||
Macrophages | Bacterial lipopolysaccharide (LPS)-induced activation | [8–10, 12]*, [13, 14] |
Macrophages | Grancalcin and host defence | [15] |
Macrophages | IL-1/TNF-induced activation | [16]* |
Macrophages | Podosome formation | [17] |
Macrophages | Zebrafish and lineage marker | [18–20] |
Macrophages | Toxoplasma gondii-infection | [21] |
Neutrophils | IL-8-induced activation | [22]* |
Neutrophils | Fc receptor and phagocytosis | [23, 24]* |
Neutrophils | L-plastin KO# and integrin | [25, 26]* |
Eosinophils | GM-CSF-induced priming | [27]* |
Osteoclasts | Podosome formation | [28] |
Osteoclasts | Sealing ring formation | [29] |
Adaptive immunity | ||
T-cells | IL-2-induced activation | [30]* |
T-cells | Accessory receptors | [31]* |
T-cells | Lymphokine-activated killer cells | [32]* |
T-cells | Costimulation | [33]* |
T-cells | CCR7 and thymus | [34] |
T-cells | LFA-1 and immune synapse | [35] |
T-cells | L-plastin KO# and impaired T cell responses | [36] |
B-cells | Marginal zone B cell development | [37] |
Suppression immunotherapies targeting L-plastin | ||
Leukocytes | Cannabinoid receptor agonists | [38] |
Leukocytes | Glucocorticoid dexamethasone | [39] |
*These studies addressed the L-plastin phosphorylation in leukocytes.
#Disruption of the L-plastin gene in mice.